The Board of Pharmacy announced a rulemaking hearing on September 27 where it is proposing to adopt the following rules. Written comments may be submitted via email to pharmacy.rulemaking@bop.oregon.gov by 4:30 p.m. on September 27.  

• Division 007 related to Compliance w/OHA COVID-19 rules 
• Divisions 019/041/043/044/139 related to Short-acting Opioid Antagonist  
• Division 045 related to USP <795> and USP <797> Standards Adopted by Reference  
• Division 115 related to Short-acting Opioid Antagonist 
• Divisions 115/125 related to RPH Applicability, Definitions, Counseling; COPT/PT Prohibited Practices 

Also in Oregon, the Board of Pharmacy adopted the following rules, effective March 1, 2024, at its August 2023 Board Meeting: 

• Division 102 related to Board Administration  
• Division 104 related to Universal Rules  
• Division 115 related to Pharmacists  
• Division 120 related to Interns and Preceptors  
• Division 125 related to Pharmacy Technicians  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Gov. Tina Kotek (D) signed SB 608, requiring the Oregon Health Authority (Medicaid) to conduct a cost of dispensing study every three years and the first study is due January 2, 2024. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Board of Pharmacy announced a rulemaking hearing on July 26 and is proposing to adopt the following rules. The rulemaking hearing will be held virtually and begins at 9:30 a.m. If you plan to testify, please complete the sign-up form on the website. Written comments may be submitted by 4:30 p.m. on July 26 via email. 

• Division 080 related to Schedule I – Xylazine
• Division 102 related to Board Administration 
• Division 104 related to Universal Rules  
• Division 115 related to Pharmacists 
• Division 120 related to Interns and Preceptors
• Division 125 related to Pharmacy Technicians  

 Also in Oregon, the Board of Pharmacy announced it will receive public comments on the following proposed compounding rules at the July 26 rulemaking hearing beginning at 9:30 a.m. If you plan to testify or submit written comments, see the above section for guidance.  

• Divisions 041/043/183 related to Drug Compounding (Please note: the board does not intend to adopt these rules in August 2023; It is only seeking public comment.) 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Oregon Board of Pharmacy permanently adopted the following rules at the June 2023 Board Meeting:  

• Divisions 006/041/043/045/080/139/141 related to Standards Adopted by Reference *Effective 6/13/2023 
• Divisions 019/020 related to Pharmacist Prescriptive Authority *Effective 6/13/2023
• Continuation of Therapy including Emergency Refills of Insulin v. 6/2023 
• Travel Medications v. 6/2023 
• HIV Post-exposure Prophylaxis (PEP) v. 6/2023 
• HIV Pre-exposure Prophylaxis (PrEP) v. 6/2023  
• Contraception v. 6/2023 
• Divisions 019/041/043/045/080/139/141/143 related to Annual Self-Inspection Form Completion Date *Effective 8/1/2023 

Also in Oregon, the House passed the following bills this week: 

• HB 2725 (A-Engrossed), legislation prohibiting PBMs from retroactively denying or reducing payment on a claim after adjudication unless the pharmacy and the PBM agree that payment was incorrect due to a clerical error and requiring PBMs, if denying or reducing reimbursement on a claim, to provide notice to the pharmacy of the specific claim that is denied or reduced and an explanation for the denial or reduction. 
• HB 3013 (B-Engrossed), legislation requiring PBMs to be licensed by the Department of Consumer & Business Services, amending the definition of “pharmacy benefit manager”, establishing a rate floor, permitting pharmacies to file a complaint with the Department of Consumer & Business Services, imposing new requirements to coverage of 340B drugs and various other provisions.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Board of Pharmacy posted an agenda for the Compounding Workgroup meeting scheduled to be held on June 20. See link below

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The June 7-9, 2023 Board of Pharmacy Meeting agenda and meeting materials are now available. Additional meeting materials may be added to the agenda prior to the board meeting. Visit the board website for current meeting materials. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Oregon Health Authority Public Health Division (OHA-PHD) announced a public hearing via Zoom on OHA-PHD’s proposal for the use of funds from the Preventive Health and Health Services Block Grant on May 31 from 1:00 p.m.-1:30 p.m. The draft proposal will be posted at www.healthoregon.org/lhd prior to the meeting. Program contact is Sara Beaudrault.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Oregon Health Authority and the Oregon Department of Human Services announced lifting of COVID-19 response measures as federal health emergency ended. Some changes were effective May 11 while others will take effect in the coming weeks. 

Also in Oregon, the Board of Pharmacy posted the agenda for the May 16 meeting of the Compounding Workgroup and the agenda for the May 17 meeting of the Public Health & Formulary Advisory Committee. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Oregon Health Authority issued a meeting notice for the Immunization Policy Advisory Team on June 1 from 12:00 noon to 2:00 p.m. The meeting will be conducted via Zoom and requires registration in advance using this link. Registrants will receive a confirmation email with additional information to join the meeting. The draft agenda appears below and the final agenda will be available by sending an email request to imm.info@oha.oregon.gov three days before the meeting date. It will also be available during the Zoom meeting. See additional details in the notice below.  

Agenda: Draft items include: 

• Public comment  
• Athletes and COVID-19 vaccine 
• Immunization uptake 
• Data analysis – small numbers policy 
• 2022 population-based rates for 2-year-olds 
• 2023 school immunization update 
• COVID-19 vaccine and therapeutics commercialization
• COVID-19 vaccine updates 

Also in Oregon, the Oregon Health Authority published a Notice of Proposed Rule Making amending Prior Authorization Approval Criteria Guide & Preferred Drug List DUR/P&T Actions. Written comments may be sent to hsd.rule@odhsoha.state.or.us no later than 5:00 p.m. on June 21.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.